Analysis of ecstasy (MDMA)-induced transcriptional responses in the rat cortex

FASEB Journal

Volumn 16, Issue 14, 2002, Pages 1887-1894

  Thiriet, Nathalie ^a   Ladenheim, Bruce ^a   McCoy, Michael T ^a   Cadet, Jean Lud ^a,b  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b Molecular Neuropsychiatry Section   (United States)

Author keywords

Arrays; CDNA; Cortex; Gene expression; MDMA; SYBR green PCR

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; COMPLEMENTARY DNA; PSYCHEDELIC AGENT; REACTIVE OXYGEN METABOLITE; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; EUPHORIA; GENE EXPRESSION; GENETIC CODE; GENETIC TRANSCRIPTION; HYPERTHERMIA; NEUROTOXICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; XENOBIOTIC METABOLISM;

ANIMALS; CEREBRAL CORTEX; CYTOSKELETAL PROTEINS; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

ANIMALIA; EUPHORIA;

EID: 0036901275     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.02-0502com     Document Type: Article

References (68)

1. McKenna, D. J., and Peroutka, S. J. (1990) Neurochemistry and neurotoxicity of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). J. Neurochem. 54, 14-22
2. Dafters, R. I. (1994) Effect of ambient temperature on hyperthermia and hyperkinesis induced by 3,4 methylenedioxymeth-amphetamine (MDMA or "ecstasy") in rats. Psychopharmacology (Berlin) 114, 505-508
3. Matthews, R. T., Champney, T. H., and Frye, G. D. (1989) Effects of (±)3,4-methylenedioxymethamphetamine (MDMA) on brain dopaminergic activity in rats. Pharmacol. Biochem. Behav. 33, 741-747
4. Liechti, M. E., Baumann, C., Gamma, A., and Vollenweider, F. X. (2000) Acute psychological effects of 3,4-methyl- enedioxymethaniphetamine (MDMA, "Ecstasy") are attenuated by the serotonin uptake inhibitor citalopram. Neuropsychopharmacology 22, 513-521
5. Gudelsky, G. A., and Nash, J. F. (1996) Carrier-mediated release of serotonin by 3,4-methylenedioxymethamphetamine: Implications for serotonin-dopamine interactions. J. Neurochem. 66, 243-249
6. Bankson, M. G., and Cunningham, K. A. (2001) 3: 4-Methyl-enedioxymethamphetamine (MDMA) as a unique model of serotonin receptor function and serotonin/dopamine interactions. J. Pharmacol. Exp. Ther. 297, 846-852
7. Vaccarino, F. M., Hayward, M. D., Le, H. N., Hartigan, D. J., Duman, R. S., and Nestler, E. J. (1993) Induction of immediate early genes by cyclic AMP in primary cultures of neurons from rat cerebral cortex. Brain Res. Mol. Brain Res. 19, 76-82
8. Lee, S. A., Park, J. K., Kang, E. K., Bae, H. R., Bae, K. W., and Park, H. T. (2000) Calmodulin-dependent activation of p38 and p42/44 mitogen-activated protein kinases contributes to c-fos expression by calcium in PC12 cells: Modulation by nitric oxide. Mol. Brain Res. 75, 16-24
9. Shirayama, Y., Hashimoto, K., Iyo, M., Watanabe, K., Higuchi, T., and Minabe, Y. (2000) 3,4-Methylenedioxymethamphetamine (MDMA, ecstasy)-induced egr-1 mRNA in rat brain: Pharmacological manipulation. Eur. J. Pharmacol. 402, 215-222
10. Stephenson, C. P., Hunt, G. E. Topple, A. N., and McGregor, I. S. (1999) The distribution of 3,4-methylenedioxymethamphetamine "Ecstasy"-induced c-fos expression in rat brain. Neuroscience 92, 1011-1023
11. Herrera, D. G., and Robertson, H. A. (1996) Activation of c-fos in the brain. Prog. Neurobiol. 50, 83-107
12. Beckmann, A. M., and Wilce, P. A. (1997) Egr transcription factors in the nervous system. Neurochem. Int. 31, 477-510; discussion 517-476
13. Ricaurte, G. A., Yuan, J., and McCann, U. D. (2000) (±)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: Studies in animals. Neuropsychobiology 42, 5-10
14. White, S. R., Obradovic, T., Imel, K. M., and Wheaton, M. J. (1996) The effects of methylenedioxymethamphetamine (MDMA, "Ecstasy") on monoaminergic neurotransmission in the central nervous system. Prog. Neurobiol. 49, 455-479
15. Schmidt, C. J. (1987) Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. J. Pharmacol. Exp. Ther. 240, 1-7
16. Colado, M. I., and Green, A. R. (1994) A study of the mechanism of MDMA ('ecstasy')-induced neurotoxicity of 5-HT neurones using chlormethiazole, dizocilpine and other protective compounds. Br. J. Pharmacol. 111, 131-136
17. Stone, D. M., Merchant, K. M., Hanson, G. R., and Gibb, J. W. (1987) Immediate and long-term effects of 3,4-methylenedioxymethamphetamine on serotonin pathways in brain of ral. Neuropharmacology 26, 1677-1683
18. Simantov, R., and Tauber, M. (1997) The abused drug MDMA (Ecstasy) induces programmed death of human serotonergic cells. FASEB J. 11, 141-146
19. Stumm, G., Schlegel, J., Schafer, T., Wurz, C., Mennel, H. D., Krieg, J. C., and Vedder, H. (1999) Amphetamines induce apoptosis and regulation of bcl-x splice variants in neocortical neurons. FASEB J. 13, 1065-1072
20. Bai, F., Jones, D. C., Lau, S. S., and Monks, T. J. (2001) Serotonergic neurotoxicity of 3,4(±)-methylenedioxyamphetamine and 3,4(±)-methylendioxymethamphetamine (ecstasy) is potentiated by inhibition of gamma-glutamyl transpeptidase. Chem. Res. Toxicol. 14, 863-870
21. Bai, F., Lau, S. S., and Monks, T. J. (1999) Glutathione and N-acetylcysteine conjugates of alpha-methyldopamine produce serotonergic neurotoxicity: Possible role in methylenedioxyamphetamine-mediated neurotoxicity. Chem. Res. Toxicol. 12, 1150-1157
22. Hiramatsu, M., Kumagai, Y., Unger, S. E., and Cho, A. K. (1990) Metabolism of methylenedioxymethamphetamine: Formation of dihydroxy methamphetamine and a quinone identified as its glutathione adduct. J. Pharmacol. Exp. Ther. 254, 521-527
23. Kumagai, Y., Lin, L. Y., Schmitz, D. A., and Cho, A. K. (1991) Hydroxyl radical mediated demethylenation of (methyl-enedioxy)phenyl compounds. Chem. Res. Toxicol. 4, 330-334
24. Colado, M. I., O'Shea, E., Granados, R., Murray, T. K., and Green, A. R. (1997) In vivo evidence for free radical involvement in the degeneration of rat brain 5-HT following administration of MDMA ('ecstasy') and p-chloroamphetamine but not the degeneration following fenfluramine. Br. J. Pharmacol. 121, 889-900
25. Shankaran, M., Yamamoto, B. K., and Gudelsky, G. A. (1999) Involvement of the serotonin transporter in the formation of hydroxyl radicals induced by 3,4-methylenedioxymethamphetamine. Eur. J. Pharmacol. 385, 103-110
26. Yeh, S. Y. (1997) Effects of salicylate on 3,4-methyl-enedioxymethamphetamine (MDMA) -induced neurotoxicity in rats. Pharmacol. Biochem. Behav. 58, 701-708
27. Aguirre, N., Barrionuevo, M., Ramirez, M. J., Del Rio, J., and Lasheras, B. (1999) Alpha-lipoic acid prevents 3,4-methyl-enedioxy-methamphetamine (MDMA) -induced neurotoxicity. NeuroReport 10, 3675-3680 1894-1895
28. Schmidt, C. J., and Kehne, J. H. (1990) Neurotoxicity of MDMA: neurochemical effects. Ann. N.Y. Acad. Sci. 600, 665-680
29. Gudelsky, G. A. (1996) Effect of ascorbate and cysteine on the 3,4-methylenedioxymethamphetamine-induced depletion of brain serotonin. J. Neural. Transm. 103, 1397-1404
30. Cadet, J. L., Ladenheim, B., Baum, I., Carlson, E., and Epstein, C. (1994) CuZn-superoxide dismutase (CuZnSOD) transgenic mice show resistance to the lethal effects of methylenedioxyamphetamine (MDA) and of methylenedioxymethamphetamine (MDMA). Brain Res. 655, 259-262
31. Cadet, J. L., Ladenheim, B., Hirata, H., Rothman, R. B., Ali, S., Carlson, E., Epstein, C., and Moran, T. H. (1995) Superoxide radicals mediate the biochemical effects of methylenedioxymethamphetamine (MDMA): Evidence from using CuZn-superoxide dismutase transgenic mice. Synapse 21, 169-176
32. Jayanthi, S., Ladenheim, B., Andrews, A. M., and Cadet, J. L. (1999) Overexpression of human copper/zinc superoxide dismutase in transgenic mice attenuates oxidative stress caused by methylenedioxymethamphetamine (Ecstasy). Neuroscience 91, 1379-1387
33. Marcotte, E. R., Srivastava, L. K., and Quirion, R. (2001) DNA microarrays in neuropsychopharmacology. Trends Pharmacol. Sci. 22, 426-436
34. Hegadoren, K. M., Baker, G. B., and Bourin, M. (1999) 3,4-Methylenedioxy analogues of amphetamine: Defining the risks to humans. Neurosci. Biobehav. Rev. 23, 539-553
35. Cadet, J. L., McCoy, M. T., and Ladenheim, B. (2002) Distinct gene expression signatures in the striata of wild-type and heterozygous c-fos knockout mice following methamphetamine administration: Evidence from cDNA array analyses. Synapse 44, 211-226
36. DeRisi, J. L., Iyer, V. R., and Brown, P. O. (1997) Exploring the metabolic and genetic control of gene expression on a genomic scale. Science 278, 680-686
37. Eisen, M. B., Spellman, P. T., Brown, P. O., and Botstein, D. (1998) Chister analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA 95, 14863-14868
38. Patterson, P. H. (1995) Cytokines in Alzheimer's disease and multiple sclerosis. Curr. Opin. Neurobiol. 5, 642-646
39. Berry, M. D., and Boulton, A. A. (2000) Glyceraldehyde-3-phosphate dehydrogenase and apoptosis. J. Neurosci. Res. 60, 150-154
40. Schaller, M. D., and Sasaki, T. (1997) Differential signaling by the focal adhesion kinase and cell adhesion kinase beta. J. Biol. Chem. 272, 25319-25325
41. Schaeffer, H. J., and Weber, M. J. (1999) Mitogen-activated protein kinases: Specific messages from ubiquitous messengers. Mol. Cell. Biol. 19, 2435-2444
42. Urade, Y., Hayaishi, O., Matsumura, H., and Watanabe, K. (1996) Molecular mechanism of sleep regulation by prostaglandin D2. J. Lipid Mediat. Cell Signal. 14, 71-82
43. Portas, C. M., Bjorvatn, B., and Ursin, R. (2000) Serotonin and the sleep/wake cycle: Special emphasis on microdialysis studies. Prog. Neurobiol. 60, 13-35
44. Morgan, M. J. (2000) Ecstasy (MDMA): a review of its possible persistent psychological effects. Psychopharmacology (Berlin) 152, 230-248
45. Granoff, M. I., and Ashby, C. R., Jr. (1998) The effect of the repeated administration of the compound 3,4-methylenedioxymethamphetamine on the response of rats to the 5-HT2A, C receptor agonist (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI). Neuropsychobiology 37, 36-40
46. Scheffel, U., Lever, J. R., Stathis, M., and Ricaurte, G. A. (1992) Repeated administration of MDMA causes transient down-regulation of serotonin 5-HT2 receptors. Neuropharmacology 31, 881-893
47. Aguirre, N., Frechilla, D., Garcia-Osta, A., Lasheras, B., and Del Rio, J. (1997) Differential regulation by methylenedioxymethamphetamine of 5-hydroxytryptamine 1A receptor density and mRNA expression in rat hippocampus, frontal cortex, and brainstem: The role of corticosteroids. J. Neurochem. 68, 1099-1105
48. Yau, J. L., Noble, J., and Seckl, J. R. (1997) Site-specific regulation of corticosteroid and serotonin receptor subtype gene expression in the rat hippocampus following 3,4-methylenedioxymethamphetamine: Role of corticosterone and serotonin. Neuroscience 78, 111-121
49. Hoyer, D., and Martin, G. (1997) 5-HT receptor classification and nomenclature: Towards a harmonization with the human genome. Neuropharmacology 36, 419-428
50. Reeves, D. C., and Lummis, S. C. (2002) The molecular basis of the structure and function of the 5-HT3 receptor: A model ligand-gated ion channel (review). Mol. Membr. Biol. 19, 11-26
51. van Hooft, J. A., and Vijverberg, H. P. (2000) 5-HT(3) receptors and neurotransmitter release in the CNS: A nerve ending story? Trends Neurosci. 23, 605-610
52. Morales, M., Battenberg, E., de Lecea, L., and Bloom, F. E. (1996) The type 3 serotonin receptor is expressed in a subpopulation of GABAergic neurons in the rat neocortex and hippocampus. Brain Res. 731, 199-202
53. Yakel, J. L., and Jackson, M. B. (1988) 5-HT3 receptors mediate rapid responses in cultured hippocampus and a clonal cell line. Neuron 1, 615-621
54. Sugita, S., Shen, K. Z., and North, R. A. (1992) 5-Hydroxytryptamine is a fast excitatory transmitter at 5-HT3 receptors in rat amygdala. Neuron 8, 199-203
55. Iwakura, Y., Nagano, T., Kawamura, M., Horikawa, H., Ibaraki, K., Takei, N., and Nawa, H. (2001) N-Methyl-D-aspartate-induced alpha-amino-3-hydroxy-5-methyl-4-isoxazoleproprionic acid (AMPA) receptor down-regulation involves interaction of the carboxyl terminus of GluR2/3 with Pick1. Ligand-binding studies using Sindbis vectors carrying AMPA receptor decoys. J. Biol. Chem. 276, 40025-40032
56. Paillart, C., Boudier, J. L., Boudier, J. A., Rochat, H., Couraud, F., and Dargent, B. (1996) Activity-induced internalization and rapid degradation of sodium channels in cultured fetal neurons. J. Cell Biol. 134, 499-509
57. Hicke, L. (1999) Gettin' down with ubiquitin: Turning off cell-surface receptors, transporters and channels. Trends Cell Biol. 9, 107-112
58. Leonardi, E. T., and Azmitia, E. C. (1994) MDMA (ecstasy) inhibition of MAO type A and type B: Comparisons with fenfluramine and fluoxetine (Prozac). Neuropsychopharmacology 10, 231-238
59. Moratalla, R., Robertson, H. A., and Graybiel, A. M. (1992) Dynamic regulation of NGFI-A (zif268, egr1) gene expression in the striatum. J. Neurosci. 12, 2609-2622
60. Marinissen, M. J., and Gutkind, J. S. (2001) G-protein-coupled receptors and signaling networks: emerging paradigms. Trends Pharmacol. Sci. 22, 368-376
61. Gurd, J. W. (1997) Protein tyrosine phosphorylation: Implications for synaptic function. Neurochem Int. 31, 635-649
62. Miller, F. D., Naus, C. C., Durand, M., Bloom, F. E., and Milner, R. J. (1987) Isotypes of alpha-tubulin are differentially regulated during neuronal maturation. J. Cell Biol. 105, 3065-3073
63. Robinson, T. E., Becker, J. B., and Presty, S. K. (1982) Long-term facilitation of amphetamine-induced rotational behavior and striatal dopamine release produced by a single exposure to amphetamine: Sex differences. Brain Res. 253, 231-241
64. Wildering, W. C., Hermann, P. M., and Bulloch, A. G. (2002) Rapid neuromodulatory actions of integrin ligands. J. Neurosci. 22, 2419-2426
65. Davies, K. J. (2000) Oxidative stress, antioxidant defenses, and damage removal, repair, and replacement systems. IUBMB Life 50, 279-289
66. Massa, S. M., Swanson, R. A., and Sharp, F. R. (1996) The stress gene response in brain. Cerebrovasc. Brain Metab. Rev. 8, 95-158
67. Mates, M. (2000) Effects of antioxidant enzymes in the molecular control of reactive oxygen species toxicology. Toxicology 153, 83-104
68. Keyse, S. M., and Tyrrell, R. M. (1989) Heme oxygenase is the major 32-kDa stress protein induced in human skin fibroblasts by UVA radiation, hydrogen peroxide, and sodium arsenite. Proc. Natl. Acad. Sci. USA 86, 99-103